%0 Journal Article %T The role of glucagon-like peptide-1 receptor agonists in cardiovascular disease prevention in type 2 diabetes mellitus: evidence from the most recent clinical trials %A Weisnagel, S. John %J Annals of Translational Medicine %D 2018 %B 2018 %9 %! The role of glucagon-like peptide-1 receptor agonists in cardiovascular disease prevention in type 2 diabetes mellitus: evidence from the most recent clinical trials %K %X The field of investigation of the prevention of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM) has seen a huge proliferation of studies on multiple drug categories and agents in the past decade. %U https://atm.amegroups.org/article/view/18959 %V 6 %N 10 %P 194 %@ 2305-5847